Last month, Revolution Medicines’ RAS inhibitor doubled survival in a Phase 3 pancreatic cancer trial. On the biotech’s heels are Immuneering, Actuate Therapeutics, Erasca and more, looking to improve ...
Longevity, the length of human life, is the subject of growing scientific and commercial interest. Click here to read more.
Japanese researchers discovered that hair graying and melanoma share a surprising cellular origin. When DNA damage strikes melanocyte stem cells, they may undergo a protective process called ...
AbbVie today announced that it will present new data at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago demonstrating the depth and breadth of its oncology pipeline.
Who is running for Maryland’s 2nd Congressional District in the 2026 election and where do candidates stand on the issues?